Amplity, a full-service commercialization partner to biopharma, has joined the American Heart Association Center for Health Technology and Innovation (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.
The Innovators’ Network is a consortium connecting entrepreneurs, providers, researchers, and payers to advance cardiovascular and brain health innovation. Innovators’ Network members also have the opportunity to access the Association’s digital evidence-based scientific guidelines and clinical recommendations as they develop digital healthcare technologies. Members collaborate with the Center in different ways, including building models for clinical outcome studies, which lowers the significant cost of developing those studies independently, helping connect the science to technology and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers.
“The Center aims to advance the rapid, efficient and effective development of healthcare technology,” said Robert A. Harrington, M.D., FAHA, volunteer past president of the American Heart Association (2019-2020), chair of the American Heart Association’s Health Tech Advisory Group for the Center and the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University. “Joining the Innovators’ Network gives members the opportunity to leverage the consortium and work toward broadening and deepening their engagement in this arena.”
“Joining the Innovators’ Network is an important step for Amplity as we continue our mission to improve patient outcomes,” said Michele Graham, President, Intel, at Amplity. “We look forward to working with the American Heart Association’s volunteers, researchers and other Innovators’ Network members to advance cardiovascular health innovation, empower greater patient awareness, and motivate healthcare providers to adopt best-in-class treatment practices.”
Amplity showcased AI platform AnswerY™, which has the powerful ability to surface real-time perceptions, during the Association’s Scientific Sessions 2025, November 9-11, in New Orleans. As part of the Health Tech Pavillion, Steve Ennen, Client Engagement Strategy, presented “Changing Minds, Healing Hearts: Using AI To Bridge Care Gaps,” on November 10.
About Amplity
Pharma At Its Best: Quicker. Better. Nicer
We are your full-service go-to partners delivering both flexible and specialized medical and commercial services. No matter where you are in the lifecycle of your drug, we scale with ease to maximize resources and improve impact. Our people-driven, tech-enabled DNA fuels everything we do.
To contact Amplity’s Marketing and PR team, please email [email protected].
